Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$828M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$788M |
| 3 |
Qualcomm
QCOM
|
+$771M |
| 4 |
Apple
AAPL
|
+$719M |
| 5 |
Baxter International
BAX
|
+$571M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.57B |
| 2 |
Wells Fargo
WFC
|
+$967M |
| 3 |
KKR & Co
KKR
|
+$455M |
| 4 |
Booking.com
BKNG
|
+$401M |
| 5 |
GGP
GGP Inc.
GGP
|
+$384M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.32% |
| 2 | Technology | 13.38% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 9.31% |
| 5 | Consumer Discretionary | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
State Street Consumer Staples Select Sector SPDR ETF
XLP
$13.7B
| $474M | 0.12% |
8,793,926
+4,345,012
| +98% | +$233M |
2013 Q2
21 quarters
|
|
177
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22B
| $474M | 0.12% |
8,083,970
+901,296
| +13% | +$51.3M |
2013 Q2
21 quarters
|
|
178
LyondellBasell Industries
LYB
$19.4B
| $474M | 0.12% |
4,620,137
+13,175
| +0.3% | +$1.44M |
2013 Q2
21 quarters
|
|
179
Bank of New York Mellon
BNY
$96.8B
| $466M | 0.12% |
9,132,243
+671,263
| +8% | +$35.3M |
2013 Q2
21 quarters
|
|
180
GE Aerospace
GE
$320B
| $461M | 0.12% |
8,518,564
-2,855,144
| -25% | -$176M |
2013 Q2
21 quarters
|
|
181
Clorox
CLX
$10.1B
| $461M | 0.12% |
3,063,813
+1,962,433
| +178% | +$279M |
2013 Q2
21 quarters
|
|
182
iShares Core US Aggregate Bond ETF
AGG
$137B
| $461M | 0.12% |
4,366,240
+360,462
| +9% | +$38.2M |
2013 Q2
21 quarters
|
|
183
iShares Russell Mid-Cap Growth ETF
IWP
$20.1B
| $458M | 0.11% |
6,758,346
-270,446
| -4% | -$18M |
2013 Q2
21 quarters
|
|
184
DELISTED
Walgreens Boots Alliance
WBA
| $456M | 0.11% |
6,248,967
+2,077,270
| +50% | +$141M |
2013 Q2
21 quarters
|
|
185
VanEck Gold Miners ETF
GDX
$26.7B
| $455M | 0.11% |
24,580,270
+10,747,954
| +78% | +$215M |
2013 Q2
21 quarters
|
|
186
Target
TGT
$69.8B
| $454M | 0.11% |
5,146,423
+255,903
| +5% | +$21.3M |
2013 Q2
21 quarters
|
|
187
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.47B
| $448M | 0.11% |
3,167,303
+43,724
| +1% | +$6.2M |
2013 Q2
21 quarters
|
|
188
Gilead Sciences
GILD
$187B
| $448M | 0.11% |
5,798,645
-151,402
| -3% | -$11.4M |
2013 Q2
21 quarters
|
|
189
iShares Russell Mid-Cap Value ETF
IWS
$15.2B
| $441M | 0.11% |
4,882,181
+154,458
| +3% | +$14M |
2013 Q2
21 quarters
|
|
190
First Trust Enhanced Short Maturity ETF
FTSM
$6.62B
| $439M | 0.11% |
7,315,209
+2,810,246
| +62% | +$169M |
2014 Q4
15 quarters
|
|
191
Ecolab
ECL
$79B
| $438M | 0.11% |
2,791,165
-6,604
| -0.2% | -$979K |
2013 Q2
21 quarters
|
|
192
State Street SPDR S&P Regional Banking ETF
KRE
$3.59B
| $437M | 0.11% |
7,356,632
+1,981,280
| +37% | +$124M |
2013 Q2
21 quarters
|
|
193
Fortis
FTS
$27.2B
| $429M | 0.11% |
13,240,227
+949,811
| +8% | +$30.9M |
2016 Q4
7 quarters
|
|
194
Prologis
PLD
$123B
| $429M | 0.11% |
6,322,461
+593,779
| +10% | +$39M |
2013 Q2
21 quarters
|
|
195
iShares MSCI USA Min Vol Factor ETF
USMV
$23.9B
| $427M | 0.11% |
7,493,696
+472,154
| +7% | +$26.3M |
2013 Q2
21 quarters
|
|
196
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.7B
| $425M | 0.11% |
1,155,237
-261,315
| -18% | -$95.7M |
2013 Q2
21 quarters
|
|
197
SL Green Realty
SLG
$3.43B
| $422M | 0.11% |
4,471,287
+28,336
| +0.6% | +$2.8M |
2013 Q2
21 quarters
|
|
198
Analog Devices
ADI
$197B
| $420M | 0.11% |
4,541,911
-2,534,372
| -36% | -$243M |
2013 Q2
21 quarters
|
|
199
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.5B
| $418M | 0.1% |
7,182,564
+22,960
| +0.3% | +$1.33M |
2013 Q2
21 quarters
|
|
200
iShares MSCI Brazil ETF
EWZ
$10.2B
| $418M | 0.1% |
12,394,883
-3,277,309
| -21% | -$110M |
2013 Q2
21 quarters
|
|
Similar funds
Morgan Stanley's Q3 2018 Portfolio in Review
As of Q3 2018, Morgan Stanley held 7,051 positions worth $400B, up 7.9% from $370B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q3 2018 filing shows 207 new, 2,867 increased, 3,205 reduced and 166 closed positions. Its largest new stake was Elanco Animal Health: 9,012,591 shares worth $314M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.57B.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, down from 30% a quarter earlier, followed by Technology and Healthcare.
- Morgan Stanley's largest Q3 2018 buy was Elanco Animal Health: 9,012,591 shares worth $314M.
- Morgan Stanley added most to Intuitive Surgical in Q3 2018, an estimated $828M increase.
- Morgan Stanley's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.57B.
- Morgan Stanley fully exited GGP Inc. in Q3 2018, selling an estimated $384M.
- Morgan Stanley's ten largest holdings make up 15% of its $400B portfolio in Q3 2018.
- Morgan Stanley opened 207 new positions and closed 166 in Q3 2018.
- Morgan Stanley's portfolio value rose 7.9% quarter-over-quarter to $400B.
Based on Morgan Stanley's 13F filing for Q3 2018, filed 14 Nov 2018.